Kalaris Therapeutics KLRS Rallies 436 as Bulls Target 516 20260520 Reviva RVPH Q3 2025 Earnings 120 EPS Surges Past 198 Estimates Expert View Gold and Silver Rates May Face Sustained Volatility in 2026 Says Kotak Securities Newmont NEM Delivers Q1 2026 Beat EPS 290 vs 220 Expected MarketAxess Holdings MKTX Delivers Q1 2026 Beat EPS 225 vs 220 Expected Nvidia Shares Edge Higher as Focus Turns to Upcoming Fiscal FirstQuarter Results